Q4 2019 Holdings
Filed 2020-02-13 | 49 holdings | $1.4M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2020-02-25) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc.A | 00461U105 | 000COMMON | $1,000.0K | 101,392,395 | 72.8% |
| Ascendis Pharma A/S | 04351P101 | 000000ADR | $298.7K | 2,552,237 | 21.8% |
| Galmed Pharmaceuticals Ltd | G63637105 | 000000SHS | $47.3K | 9,610,156 | 3.4% |
| Orchard Therapeutics plc | 68570P101 | 000000ADS | $26.6K | 2,805,035 | 1.9% |